Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2009
09/09/2009EP2097372A1 Process for the preparation of memantine and its hydrochloric acid salt form
09/09/2009EP2097371A2 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity
09/09/2009EP2097109A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
09/09/2009EP2097083A2 Dosage forms and co-administration of an opioid agonist and an opioid antagonist
09/09/2009EP2097079A2 Modulation of prostaglandin/cyclooxygenase metabolic pathways
09/09/2009EP2097070A1 Robust sustained release formulations of oxymorphone and methods of use thereof
09/09/2009EP2097069A1 Robust sustained release formulations of oxymorphone
09/09/2009EP2096927A2 Therapeutic compositions and methods of treatment with capsianoside-type compounds
09/09/2009EP1957488B1 3-amino-2-arylpropyl azaindoles and uses thereof
09/09/2009EP1838677B1 Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
09/09/2009EP1732917B8 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
09/09/2009EP1515947B1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament
09/09/2009EP1509621B1 Diagnostic of alzheimer's disease by analysis of il-10 gene polymorphisms
09/09/2009EP1474150B1 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of cardiac insufficiency
09/09/2009EP1446733B1 Glycosylphosphatidylinositol containing polypeptides
09/09/2009EP1392326B1 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
09/09/2009EP0939659B1 Device for transdermal electrotransport delivery of fentanyl and sufentanil
09/09/2009EP0861261B1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
09/09/2009EP0813545B1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
09/09/2009CN101528209A Oleanane triterpene saponin compounds which are effective on treatment of dementia and mild cognitive impairment(MCI), and improvement of cognitive function
09/09/2009CN101525570A Glossy ganoderma-ginseng sedative wine
09/09/2009CN101525384A A bispecific antibody and the making method and the application thereof
09/09/2009CN101525333A Synthesis method of metixene hydrochloride
09/09/2009CN101524519A Chinese materia medica preparation for treating insomnia and preparation method thereof
09/09/2009CN101524513A Health pillow drug core
09/09/2009CN101524493A Multifunctional Chinese medicine honeyed pill
09/09/2009CN101524394A Quezui tea preparation and application thereof
09/09/2009CN101524385A Preparation process for ginseng extract
09/09/2009CN101524384A Preparation process for manyprickle acathopanax root extract
09/09/2009CN101524381A Ginkgo pollen extractive and preparation method and application thereof
09/09/2009CN101524377A Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof
09/09/2009CN101524375A Wet-process wall breaking method of lucidum spore powder
09/09/2009CN101524370A Production technology of pig brain protolysate
09/09/2009CN101524361A Process for preparing adenosine analogue and its application
09/09/2009CN101524350A Application of N-methyl-N-benzyl-3-chloro-6-methoxyl-benzothiophene -2-formamide
09/09/2009CN101524346A Application of conjugated linoleic acid (CLA) in preparing drugs for treating Alzheimer disease
09/09/2009CN101524345A Medicine composition without any excipients and preparation process thereof
09/09/2009CN101524342A Use of injection sodium vedproate in psychiatric department treatment
09/09/2009CN101524339A Fentanyl patch
09/09/2009CN101524337A Prolonged release mucosal bioadhesive system
09/09/2009CN101524232A Concave medicine pillow
09/09/2009CN101524227A Production method of silk quilt for treating insomnia and improving sleep quality
09/09/2009CN101524226A Production method of silk quilt for treating neurasthenia
09/09/2009CN101524190A Disease preventing and curing medicinal mouth-muffle and medicinal composite
09/09/2009CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof
09/09/2009CN100537546C Novel alkansulfonamides as endothelin antagonists
09/09/2009CN100537527C Aryl and biaryl compounds having MCH modulatory activity
09/09/2009CN100537520C N-bridged selective androgen receptor modulators and methods of use thereof
09/09/2009CN100536919C Interferon antagon and usage of Flt3L antagon
09/09/2009CN100536915C 神经毒素植入物 Neurotoxin implant
09/09/2009CN100536857C Soft capsule of extractive from leaves of persimmon and self-emulsifying system for releasing drug
09/09/2009CN100536851C Phospholipid derivatives of valproic acid and mixtures thereof
09/09/2009CN100536839C Urea derivatives as integrin alpha 4 antagonists
09/08/2009US7585974 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application
09/08/2009US7585880 Phenylpropanoic acid derivatives
09/08/2009US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder
09/08/2009US7585876 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
09/08/2009US7585873 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
09/08/2009US7585860 Substituted oxazolidinones and their use in the field of blood coagulation
09/08/2009US7585853 Compounds having selective inhibiting effect at GSK3
09/08/2009US7585507 Nucleic acid molecules and polypeptides for immune modulation
09/08/2009US7585502 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunization
09/08/2009CA2522813C 2-alkynyl-and 2-alkenyl-pyrazolo-¬4,3-e|-1,2,4-triazolo-¬1,5-c|-pyrimidine adenosine a2a receptor antagonists
09/08/2009CA2478066C Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
09/08/2009CA2468833C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
09/08/2009CA2463598C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists
09/08/2009CA2442210C Aryl oxime-piperazines useful as ccr5 antagonists
09/08/2009CA2417758C Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches
09/08/2009CA2366820C Novel [(2-substituted-5 -[3-thienyl) -benzyl]-[2- ([2-isopropoxy-5-fluoro] -phenoxy) -ethyl] -amine derivatives, method for the production and use thereof as medicaments
09/08/2009CA2360360C Piperidyl benzamide compounds, composition containing same and their use thereof
09/08/2009CA2348319C Cyclohexenol derivative and medicament containing the same
09/08/2009CA2342739C Azetidine derivatives, preparation and medicines containing them
09/08/2009CA2341010C Process for the manufacture of ethanesulfonyl-piperidine derivatives
09/08/2009CA2335623C Aminoiminoquinone and aminoquinine alkaloid compounds as capase inhibitors
09/08/2009CA2329636C Riluzole and levodopa combinations for treating parkinson's disease
09/08/2009CA2292017C Substituted cycloheptenes, their preparation and use
09/08/2009CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4
09/03/2009WO2009108804A2 Steroid analogues for neuroprotection
09/03/2009WO2009108766A1 Gamma secretase modulators for the treatment of alzheimer ' s disease
09/03/2009WO2009108657A2 Heteroaryl derivatives as cftr modulators
09/03/2009WO2009108632A1 Compositions and methods for using stromal cells to enhance treatment of central nervous system injuries
09/03/2009WO2009108376A2 Contrast agents for applications including perfusion imaging
09/03/2009WO2009108117A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177
09/03/2009WO2009107478A1 Adhesive skin patch and packaged product
09/03/2009WO2009107401A1 Kit, composition, product or medicament for treating cognitive impairment
09/03/2009WO2009107391A1 Compound having 6-membered aromatic ring
09/03/2009WO2009107387A1 2-oxochromene derivative
09/03/2009WO2009106982A1 Indazole derivatives
09/03/2009WO2009106980A2 Indazole derivatives
09/03/2009WO2009106855A1 NOVEL USES OF VEGFxxxB
09/03/2009WO2009106831A2 Pharmaceutical composition
09/03/2009WO2009106769A1 5-[1'-(decahydro-7-hydroxy-1,1,3a,7-tetramethyl-1h-cyclopropa[a]naphtalen-4-yl)-3'-methylbutyl]-2,4,6-trihydroxy-1,3-benzenedicarboxaldehyde used as drugs
09/03/2009WO2009106752A2 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereof and therapeutic application thereof
09/03/2009WO2009106751A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/03/2009WO2009106749A2 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/03/2009WO2009106748A2 Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/03/2009WO2009106708A2 Azetidine derivatives, their preparation and their application in therapy
09/03/2009WO2009106574A2 Combinations for treating hiv-associated pain
09/03/2009WO2009106534A1 Novel heterocyclic carboxamides as m1 agonists
09/03/2009WO2009106516A1 Compositions, kits and methods for a titration schedule for pardoprunox compounds